Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1146/annurev-med-052716-031710 http://scihub22266oqcxt.onion/10.1146/annurev-med-052716-031710 C5892446!5892446!29099677     free     free     free       Annu+Rev+Med 2018 ; 69 (ä): 421-36 Nephropedia Template TP {{tp|p=29099677|t=2018. Novel Latency Reversing Agents for HIV-1 Cure |pdf=|usr=}}{{29099677}} gab.com Text Novel Latency Reversing Agents for HIV-1 Cure JO: Annu Rev Med http://www.kidney.de/pget.php?&tw=1&pmid=29099677 #FOAvip Antiretroviral therapy (ART) has rendered HIV-1 infection a treatable illness, however ART is not curative due to the persistence of replication-competent, latent proviruses in long-lived resting T cells. Strategies that target these latently infected cells and allow for immune recognition and clearance of this reservoir will be necessary to eradicate HIV-1 in infected individuals. This review describes current pharmacologic approaches to reactivate the latent reservoir in a manner that infected cells can be recognized and targeted, with the ultimate goal of achieving an HIV-1 cure. Twit Text FOAVip Novel Latency Reversing Agents for HIV-1 Cure ????Annu Rev Med http://www.kidney.de/pget.php?&tw=1&pmid=29099677 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29099677 #FOAvip English Wikipedia <ref>{{Cite pmid|29099677}}</ref> Novel Latency Reversing Agents for HIV-1 Cure #MMPMID29099677 Spivak AM; Planelles V Annu Rev Med 2018[Jan]; 69 (ä): 421-36 PMID29099677show ga Antiretroviral therapy (ART) has rendered HIV-1 infection a treatable illness, however ART is not curative due to the persistence of replication-competent, latent proviruses in long-lived resting T cells. Strategies that target these latently infected cells and allow for immune recognition and clearance of this reservoir will be necessary to eradicate HIV-1 in infected individuals. This review describes current pharmacologic approaches to reactivate the latent reservoir in a manner that infected cells can be recognized and targeted, with the ultimate goal of achieving an HIV-1 cure. äNovel Latency Reversing Agents for HIV-1 Cure (epmc).pdf DeepDyve Pubget Overpricing